Sinasprite: A Pilot Feasibility Study for Patients With Anxiety or Stress
NCT02955784 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2024-12-24
Summary
The investigators are proposing a prospective one-arm cohort study testing the feasibility of a game designed to improve symptoms in adults with mild levels of stress, depression, and anxiety. The study will take place at Madigan Army Medical Center. Primary outcomes include usage data including time, frequency and duration of app use, participant satisfaction with the game, and comments and suggestions regarding participants' experiences using the Sinasprite game over a 12-week period. Participants will download Litesprite's game, Sinasprite, onto their personal smartphone. Elements of cognitive-behavioral therapies like cognitive strategies, diaphragmatic breathing, and visualization are embedded in the game enabling participants to learn to achieve the desired healthy habits. The game's goal is to help Socks the Fox become a Zen Master. Over six weeks, players help Socks to progress by describing and categorizing their concerns, entrusting Socks to "hold" these concerns, and engaging in bonding activities with Socks, such as fishing and meditation. The investigators currently have a prototype and have been told by insurance firms, providers, and self-funded employers that they need to see validated results from a pilot study that shows feasibility with subjects in the target audience before they can consider a commercial roll out. Participants will complete questions related to mood, stress, and well-being at baseline, 6 weeks, and 12 weeks. Data will be evaluated in real-time and reports of participant progress will be provided to the participant's provider, with the participant's consent. Data and feedback from this pilot study will be used to update the design and inform the technical development team to further refine the game experience in preparation for a larger randomized controlled trial evaluating the effectiveness of Sinasprite.
Conditions
- Stress
- Depression
- Anxiety
Interventions
- DEVICE
-
Sinasprite Mobile App
Mobile App
Sponsors & Collaborators
-
Madigan Army Medical Center
lead FED
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-01-22
- Primary Completion
- 2018-02-14
- Completion
- 2018-02-14
Countries
- United States
Study Locations
More Related Trials
-
Ketamine and Nitroprusside for Depression
NCT03102736 ·Status: COMPLETED ·Phase: PHASE2
-
The ISLAND Study: InSuLa Assessed Needs for Depression
NCT02137369 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Medication and Placebo Response in Major Depression
NCT00229476 ·Status: COMPLETED ·Phase: PHASE4
-
Chinese Herb for the Treatment of Depression and Anxiety Disorders
NCT03323697 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Sertraline vs. Placebo for Symptoms Following Traumatic Brain Injury
NCT00208585 ·Status: UNKNOWN ·Phase: NA
-
Assessment of the Effect of Sertaline on the Specific Binding of 123-I MZINT in Healthy Subjects
NCT00470925 ·Status: TERMINATED ·Phase: PHASE1
-
Mineralocorticoid Receptor in the Treatment of Severe Depression
NCT00295347 ·Status: COMPLETED ·Phase: NA
-
Are Patients Suffering From DSPS Show Compromising in Everyday Functions and Abilities Before Handling the Disorder?
NCT02962037 ·Status: UNKNOWN ·Phase: PHASE4
-
Cognitive and Drug Therapy for Drug-Resistant Depression
NCT00000376 ·Status: COMPLETED ·Phase: NA
-
Double-blind Pilot Trial of Mirtazapine for the Treatment of Co-occurring AD/MDD.
NCT02185131 ·Status: COMPLETED ·Phase: PHASE2
-
Study Of Indiplon/Placebo With Sertraline In Insomnia Co-Existing With Depression
NCT00232167 ·Status: TERMINATED ·Phase: PHASE3
-
Evaluation of Stress Disorders
NCT00050804 ·Status: COMPLETED ·Phase: PHASE4
-
Pilot Study of Riluzole for Drug-Refractory Irritability in Autism Spectrum Disorders
NCT02081027 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Treatment of Mild and Subthreshold Depressive Disorders
NCT00226642 ·Status: UNKNOWN ·Phase: PHASE4
-
Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders
NCT06081348 ·Status: RECRUITING ·Phase: PHASE2
-
Serotonin Selective Reuptake Inhibitor Treatment of Dual Diagnosis Post-traumatic Stress Disorder and Alcohol Problems
NCT02504931 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Citalopram for Anxiety Disorders Following a Traumatic Brain Injury
NCT00208572 ·Status: UNKNOWN ·Phase: NA
-
Sequential Therapy for the Treatment of Severe Bipolar Depression.
NCT02974010 ·Status: COMPLETED ·Phase: PHASE2
-
Neuropattern - Assessment of a Translational Diagnostic Tool for Depression, Adjustment- and Somatoform-disorders
NCT01062880 ·Status: UNKNOWN ·Phase: NA
-
Rapamycin as a Means of Interference With Reconsolidation of Posttraumatic Stress Disorder-related Traumatic Memory
NCT01449955 ·Status: COMPLETED ·Phase: NA
-
Predicting SSRI Efficacy in Veterans With PTSD
NCT04183205 ·Status: TERMINATED ·Phase: PHASE4
-
Psilocybin With Pimavanserin Compared to Psilocybin Alone for the Treatment of Major Depressive Disorder
NCT06592833 ·Status: RECRUITING ·Phase: PHASE2
-
SSRI Administration to Reduce Acute Stress Disorder Symptoms and Prevent Depression and PTSD in Physical Trauma Victims
NCT00114374 ·Status: TERMINATED ·Phase: PHASE3
-
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
NCT06559306 ·Status: RECRUITING ·Phase: PHASE3
-
Thyroid Medication and Antidepressants for Treating Major Depression
NCT00208702 ·Status: COMPLETED ·Phase: PHASE4